Insilico Medicine’s COVID-19 Drug ISM3312 Enters Clinical Trials
China-based AI-powered drug discovery firm Insilico Medicine has announced that its ISM3312, an oral COVID-19...
Company
Meihua International Partners with Hainan for Medical Tech Park and R&D Center
Meihua International Medical Technologies Co., Ltd (NASDAQ: MHUA), a specialist in Chinese medical consumables, has...
Kactus Biosystems and Levinthal Biotech Deepen Strategic Partnership
Kactus Biosystems, a Shanghai-based firm specializing in target proteins and raw enzymes, has announced a...
Junshi Biosciences’ PD-1 Inhibitor Tuoyi Shows Promise in Phase III TNBC Study
Junshi Biosciences Co., Ltd (HKG: 1877, SHA: 688180) has announced significant progress in the Phase...
Abbott Partners with Sinopharm for Expanded Medical Solutions in China
US-based Abbott (NYSE: ABT) has entered into a strategic partnership with Sinopharm’s China National Medical...
Luoxin’s Tegoprazan Gains NMPA Review for Duodenal Ulcer Treatment
Shandong Luoxin Pharmaceutical Group Stock Co., Ltd (SHE: 002793), a leading China-based pharmaceutical company, has...
Shanghai Pharmaceuticals’ X842 Accepted for NMPA Review for Reflux Esophagitis
China-based Shanghai Pharmaceuticals Holding Co., Ltd (SHA: 601607) has announced that the National Medical Products...
We-Linking Raises Tens of Millions in Angel Round for Brain-Computer Interface
We-Linking, a developer of fully implantable wireless brain-computer interface systems based in Shenzhen, has reportedly...
Hybio Pharma and CR Medicine Collaborate on Market Expansion
China-based Hybio Pharmaceutical Co., Ltd (SHE: 300199) has entered into a collaboration agreement with compatriot...
Junshi Biosciences Seeks UK MHRA Approval for PD-1 Inhibitor Tuoyi
Junshi Biosciences (HKG: 1877, SHA: 688180), a leading China-based biotech firm, has announced the submission...
Chinagene Tech Initiates ZVS101e Gene Therapy Trial for Bietti’s Crystalline Dystrophy
Beijing-based Chinagene Tech, a specialist in hereditary ophthalmopathy diagnosis and gene therapy, has announced the...
Ascletis Pharma’s ASC10 Shows Promising Phase I Results at CROI 2023
China-based Ascletis Pharma Inc. (HKG: 1672) has announced positive results from a Phase I clinical...
Beijing Huashen Shengdian Secures Angel Funding for Pelvic Surgery Monitor R&D
China-based intraoperative nerve monitoring technology developer Beijing Huashen Shengdian Medical Technology Co., Ltd has reportedly...
Zhaoke’s Generic Bimatoprost + Timolol Maleate Eye Drops Approved in China
Lee’s Pharmaceutical Holdings Ltd (HKG: 0950) former subsidiary Zhaoke Ophthalmology Ltd (HKG: 6622) has announced...
Sino Biopharmaceutical’s Limaprost Approved by NMPA for Lumbar Spinal Stenosis Treatment
Sino Biopharmaceutical Ltd (HKG: 1177) has announced that it has received marketing approval from China’s...
Biocytogen’s ‘Nano 100 Project’ Aims to Develop Over 100 Fully Human Nanobody Drugs
China-based Biocytogen Pharmaceuticals (Beijing) Co., Ltd has announced the launch of the “Nano 100 Project,”...
Biosyngen’s BRG01 Gets FDA Nod for NPC Clinical Study
Cell and gene therapy (CGT) specialist Biosyngen Pte Ltd has announced receiving approval from the...
China’s 8th Volume-Based Procurement Round Begins Drug Info Filing
The national drug alliance procurement office has released a notification initiating the drug information filing...
BRL Medicine Achieves First Cure of Thalassemia Major with BRL-101
Shanghai-based BRL Medicine Inc. has announced a significant breakthrough in the treatment of thalassemia major....